0 NASDAQ Companies - March 29, 2019ASLAN Pharmaceuticals Completes First Part of Single Ascending Dose Study for ASLAN004 Targeting Atopic DermatitisRead More
0 Canadian Stock Exchange News - March 29, 2019FinCanna Comments on Congressional Committee Approval for Cannabis Banking BillRead More
0 NASDAQ Companies - March 29, 2019Chi-Med Initiates a Phase IIb/III Trial of Surufatinib in Patients with Unresectable or Metastatic Biliary Tract Cancer in ChinaRead More
0 NASDAQ Companies - March 29, 2019Publication of ObsEva SA Invitation to 2019 Annual General Meeting of ShareholdersRead More
0 NASDAQ Companies - March 29, 2019AC Immune Presents New Data on Alpha-Synuclein PET Tracer at AD/PD™ ConferenceRead More
0 TSX News - March 29, 2019TransGlobe Energy Corporation Exercise of Share Plan Options and Director PDMR DealingsRead More
